Organigram Holdings Inc (OGI)

$1.63

-0.13

(-7.41%)

Market is closed - opens 7 PM, 25 Jul 2024

Performance

  • $1.62
    $1.75
    $1.63
    downward going graph

    0.92%

    Downside

    Day's Volatility :7.71%

    Upside

    6.85%

    downward going graph
  • $0.97
    $2.91
    $1.63
    downward going graph

    40.48%

    Downside

    52 Weeks Volatility :66.66%

    Upside

    43.99%

    downward going graph

Returns

PeriodOrganigram Holdings IncSector (Health Care)Index (Russel 2000)
3 Months
-9.07%
5.5%
0.0%
6 Months
2.03%
7.2%
0.0%
1 Year
29.04%
9.3%
0.0%
3 Years
-82.99%
13.0%
-19.9%

Highlights

Market Capitalization
184.1M
Book Value
$2.88
Earnings Per Share (EPS)
-1.82
Wall Street Target Price
8.8
Profit Margin
-153.8%
Operating Margin TTM
-39.8%
Return On Assets TTM
-5.56%
Return On Equity TTM
-54.53%
Revenue TTM
149.2M
Revenue Per Share TTM
1.84
Quarterly Revenue Growth YOY
-14.000000000000002%
Gross Profit TTM
35.1M
EBITDA
-25.4M
Diluted Eps TTM
-1.82
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.37
EPS Estimate Next Year
-0.09
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    72%Buy
    27%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Organigram Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
7
7
Hold
3
4
5
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 439.88%

Current $1.63
Target $8.80

Technicals Summary

Sell

Neutral

Buy

Organigram Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Organigram Holdings Inc
Organigram Holdings Inc
11.78%
2.03%
29.04%
-82.99%
-92.61%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
8.85%
3.8%
45.41%
51.86%
68.72%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
2.31%
10.22%
1.49%
19.3%
19.3%
Zoetis Inc.
Zoetis Inc.
4.39%
-3.6%
-3.34%
-10.68%
55.39%
Viatris Inc.
Viatris Inc.
9.84%
-1.88%
8.29%
-16.91%
-29.62%
Catalent, Inc.
Catalent, Inc.
3.45%
17.64%
21.86%
-48.3%
5.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Organigram Holdings Inc
Organigram Holdings Inc
NA
NA
NA
-0.37
-0.55
-0.06
NA
2.88
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
39.48
39.48
0.44
3.98
0.18
0.1
NA
23.72
Haleon Plc Spon Ads
Haleon Plc Spon Ads
29.73
29.73
1.69
0.39
0.07
0.04
0.02
1.8
Zoetis Inc.
Zoetis Inc.
34.83
34.83
2.58
5.77
0.5
0.14
0.01
11.07
Viatris Inc.
Viatris Inc.
224.4
NA
0.06
2.73
0.0
0.03
0.04
16.81
Catalent, Inc.
Catalent, Inc.
211.02
NA
2.06
0.2
-0.28
-0.01
NA
19.96
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Organigram Holdings Inc
Organigram Holdings Inc
Buy
$184.1M
-92.61%
NA
-153.8%
Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc.
Buy
$14.6B
68.72%
39.48
18.65%
Haleon Plc Spon Ads
Haleon Plc Spon Ads
Buy
$40.7B
19.3%
29.73
9.64%
Zoetis Inc.
Zoetis Inc.
Buy
$82.5B
55.39%
34.83
27.38%
Viatris Inc.
Viatris Inc.
Hold
$13.8B
-29.62%
224.4
-0.37%
Catalent, Inc.
Catalent, Inc.
Hold
$10.5B
5.41%
211.02
-28.44%

Insights on Organigram Holdings Inc

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 36.45M → 37.62M (in $), with an average increase of 1.6% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -15.75M → -27.07M (in $), with an average decrease of 36.0% per quarter

  • Vs NBIX

    In the last 1 year, Neurocrine Biosciences Inc. has given 45.4% return, outperforming this stock by 16.4%

  • Vs NBIX

    In the last 3 years, Neurocrine Biosciences Inc. has given 47.6% return, outperforming this stock by 129.8%

Institutional Holdings

  • Highbridge Capital Management, LLC

    3.11%
  • Tidal Investments LLC.

    1.69%
  • AdvisorShares Investments, LLC

    0.87%
  • Murchinson Ltd.

    0.79%
  • Renaissance Technologies Corp

    0.56%
  • NewGen Asset Management Ltd

    0.56%

Company Information

as part of canada’s marihuana for medical purposes regulations (mmpr), organigram (tsx-v:ogi) is atlantic canada's original licensed producer of medical marijuana. we are dedicated to consistently providing our clients with the highest quality, organically grown medicine and service. if you have questions or want to learn more, visit www.organigram.ca or give our client services team a call at 1-855-961-9420.

Organization
Organigram Holdings Inc
Employees
987
CEO
Ms. Beena G. Goldenberg
Industry
Pharmaceuticals: Other

FAQs